3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
9
Recruiting
3
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
234
INDUSTRY
11
OTHER_GOV
3
NETWORK
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Genitourinary
1
CNS
1
Conditions
Radiation Injuries
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Neoplasms
1
Hematologic Neoplasms
1
Brain Neoplasms
1
Interventions
Drug Therapy
10
pembrolizumab
9
Bevacizumab
9
Radiotherapy
8
Cyclophosphamide
8
Carboplatin
8
Oxaliplatin
7
tislelizumab
6
Surgical Procedures, Operative
6
Docetaxel
6
Cisplatin
6
Capecitabine
6
Paclitaxel
5
Nivolumab
5
Fluorouracil
5
Control Groups
5
fludarabine
4
Immune Checkpoint Inhibitors
4
Gemcitabine
4
Endoscopic Mucosal Resection
4
sintilimab
3
Trastuzumab
3
Pemetrexed
3
Neoadjuvant Therapy
3
Leucovorin
3
Laparoscopy
3
Irinotecan
3
Injections
3
Hematologic Tests
3
HMPL-013
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER_GOV
×
Blood Specimen Collection
×
Clear all
NCT06618703
2026-04-06
BIChE-1
University Hospital, Angers
Phase NA
Recruiting
230 enrolled
NCT04691284
2025-05-29
SCTMICROBIOM
National Cancer Institute, Slovakia
Phase NA
Recruiting
100 enrolled
NCT06116851
2023-11-03
PROMIC
Turku University Hospital
Recruiting
300 enrolled